Literature DB >> 18094999

N-acetyl-L: -cysteine reduces the parasitism of BALB/c mice infected with Leishmania amazonensis.

Marta Chagas Monteiro1, Fúlvia Carina Souza Marques, Renê Darela Blazius, Onilda Santos da Silva, Fernando de Queiroz Cunha, Diana Bittencourt Bento, Pedro Roosevelt Torres Romão.   

Abstract

Leishmania amazonensis infection leads to progressive diseases in a majority of inbred strains of mice. Glutathione (GSH) participates in a large number of cellular phenomena and seems to be essential for several immune functions, including host defense during leishmaniasis. In this study, we evaluated the effects of N-acetyl-L: -cysteine (NAC), as GSH supplement, on the course of L. amazonensis infection in susceptible BALB/c mice. The treatment with NAC (200 mg/kg daily) was effective in raising GSH levels in both lymph node and spleen cells. Although this treatment did not change the footpad swelling development in L. amazonensis-infected mice, it caused a significant decrease in the number of parasites recovered from the footpad lesion and draining popliteal lymph node. Our data suggest that intracellular Leishmania killing in vivo was improved by the augment of GSH levels through NAC administration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18094999     DOI: 10.1007/s00436-007-0827-x

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  16 in total

Review 1.  Glutathione metabolism and its implications for health.

Authors:  Guoyao Wu; Yun-Zhong Fang; Sheng Yang; Joanne R Lupton; Nancy D Turner
Journal:  J Nutr       Date:  2004-03       Impact factor: 4.798

2.  Promotion of cystine uptake and its utilization for glutathione biosynthesis induced by cysteamine and N-acetylcysteine.

Authors:  R D Issels; A Nagele; K G Eckert; W Wilmanns
Journal:  Biochem Pharmacol       Date:  1988-03-01       Impact factor: 5.858

3.  Glutathione and the redox control system trypanothione/trypanothione reductase are involved in the protection of Leishmania spp. against nitrosothiol-induced cytotoxicity.

Authors:  P R T Romão; J Tovar; S G Fonseca; R H Moraes; A K Cruz; J S Hothersall; A A Noronha-Dutra; S H Ferreira; F Q Cunha
Journal:  Braz J Med Biol Res       Date:  2006-02-22       Impact factor: 2.590

4.  Glutathione protects macrophages and Leishmania major against nitric oxide-mediated cytotoxicity.

Authors:  P R Romão; S G Fonseca; J S Hothersall; A A Noronha-Dutra; S H Ferreira; F Q Cunha
Journal:  Parasitology       Date:  1999-06       Impact factor: 3.234

5.  Glutathione protects mice from lethal sepsis by limiting inflammation and potentiating host defense.

Authors:  Pia Villa; Alessandra Saccani; Antonio Sica; Pietro Ghezzi
Journal:  J Infect Dis       Date:  2002-04-01       Impact factor: 5.226

6.  The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid.

Authors:  O I Aruoma; B Halliwell; B M Hoey; J Butler
Journal:  Free Radic Biol Med       Date:  1989       Impact factor: 7.376

7.  Role of interleukin-4 and prostaglandin E2 in Leishmania amazonensis infection of BALB/c mice.

Authors:  Elisalva T Guimarães; Luana A Santos; Ricardo Ribeiro dos Santos; Mauro M Teixeira; Washington L C dos Santos; Milena B P Soares
Journal:  Microbes Infect       Date:  2006-01-19       Impact factor: 2.700

8.  Leishmania braziliensis: partial control of experimental infection by interleukin-12 p40 deficient mice.

Authors:  Sebastião Martins de Souza-Neto; Cláudia Martins Carneiro; Leda Quercia Vieira; Luís Carlos Crocco Afonso
Journal:  Mem Inst Oswaldo Cruz       Date:  2004-07-19       Impact factor: 2.743

9.  The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis.

Authors:  Udaikumar M Padigel; James Alexander; Jay P Farrell
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

10.  Thiols decrease human interleukin (IL) 4 production and IL-4-induced immunoglobulin synthesis.

Authors:  P Jeannin; Y Delneste; S Lecoanet-Henchoz; J F Gauchat; P Life; D Holmes; J Y Bonnefoy
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

View more
  6 in total

1.  Oxidative stress fuels Trypanosoma cruzi infection in mice.

Authors:  Claudia N Paiva; Daniel F Feijó; Fabianno F Dutra; Vitor C Carneiro; Guilherme B Freitas; Letícia S Alves; Jacilene Mesquita; Guilherme B Fortes; Rodrigo T Figueiredo; Heitor S P Souza; Marcelo R Fantappié; Joseli Lannes-Vieira; Marcelo T Bozza
Journal:  J Clin Invest       Date:  2012-06-25       Impact factor: 14.808

Review 2.  Are reactive oxygen species always detrimental to pathogens?

Authors:  Claudia N Paiva; Marcelo T Bozza
Journal:  Antioxid Redox Signal       Date:  2013-10-26       Impact factor: 8.401

Review 3.  Immunoregulation in human American leishmaniasis: balancing pathology and protection.

Authors:  K J Gollob; A G Viana; W O Dutra
Journal:  Parasite Immunol       Date:  2014-08       Impact factor: 2.280

4.  DETC induces Leishmania parasite killing in human in vitro and murine in vivo models: a promising therapeutic alternative in Leishmaniasis.

Authors:  Ricardo Khouri; Fernanda Novais; Gisélia Santana; Camila Indiani de Oliveira; Marcos André Vannier dos Santos; Aldina Barral; Manoel Barral-Netto; Johan Van Weyenbergh
Journal:  PLoS One       Date:  2010-12-21       Impact factor: 3.240

5.  Trypanosoma cruzi Needs a Signal Provided by Reactive Oxygen Species to Infect Macrophages.

Authors:  Grazielle R Goes; Peter S Rocha; Aline R S Diniz; Pedro H N Aguiar; Carlos R Machado; Leda Q Vieira
Journal:  PLoS Negl Trop Dis       Date:  2016-04-01

6.  Carajurin Induces Apoptosis in Leishmania amazonensis Promastigotes through Reactive Oxygen Species Production and Mitochondrial Dysfunction.

Authors:  João Victor Silva-Silva; Carla J Moragas-Tellis; Maria S S Chagas; Paulo Victor R Souza; Davyson L Moreira; Daiana J Hardoim; Noemi N Taniwaki; Vanessa F A Costa; Alvaro L Bertho; Daniela Brondani; Eduardo Zapp; Aldo Sena de Oliveira; Kátia S Calabrese; Maria D Behrens; Fernando Almeida-Souza
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.